Gasdermin family: a promising therapeutic target for cancers and inflammation-driven diseases
JOURNAL OF CELL COMMUNICATION AND SIGNALING
Authors: Wu, Danbin; Chen, Yefei; Sun, Yingxin; Gao, Qing; Yu, Bin; Jiang, Xijuan; Guo, Maojuan
Abstract
This review focuses on current advances in researches of gasdermin family. The distinctive expression patterns and biological roles of members in this family were discussed. Most of them exhibit pore-forming activity on cell membranes and are executors for programmed cell death with cytokines release, and play roles in cancers and inflammation-driven diseases. Therefore, they can be used as potential therapeutic targets to treat related diseases.
Chromosomal mapping of two members of the human dynein gene family to chromosome regions 7p15 and 11q13 near the deafness loci DFNA 5 and DFNA 11
GENOMICS
Authors: Kastury, K; Taylor, WE; Gutierrez, M; Ramirez, L; Coucke, PJ; VanHauwe, P; VanCamp, G; Bhasin, S
Abstract
We mapped expressed tagged sequences (ESTs) corresponding to two human dynein heavy chain genes: beta heavy chain of the outer dynein arm and heavy chain isotype 1B (DYH1B), by using somatic cell hybrids and radiation hybrid panels, The EST for the beta heavy chain of the outer dynein arm mapped to chromosome region 7p15, and the EST for DYH1B mapped to 11q13.5. Two loci for nonsyndromic forms of deafness, DFNA5 and DFNA11, have previously been mapped to these two chromosomal regions, Including the gene for the axonemal light chain, hp28, we have mapped three different dynein genes near loci for different forms of nonsyndromic deafness. The hypothesis that mutations in some dynein genes are associated with nonsyndromic deafness should now be tested. (C) 1997 Academic Press.